Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapyWen Xu, Annie LM Cheung|Oncotarget|2014Cited by 70
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical SignificanceBin Li, Annie LM Cheung|Theranostics|2019Cited by 58